-
公开(公告)号:US09249158B2
公开(公告)日:2016-02-02
申请号:US14390246
申请日:2013-04-03
申请人: Lee Fader , Pierre Louis Beaulieu , Murray Bailey , Francois Bilodeau , Rebekah J. Carson , André Giroux , Cédrickx Godbout , Oliver Hucke , Marc-André Joly , Mélissa Leblanc , Olivier Lepage , Benoit Moreau , Julie Naud , Martin Poirier , Elisia Villemure
发明人: Lee Fader , Pierre Louis Beaulieu , Murray Bailey , Francois Bilodeau , Rebekah J. Carson , André Giroux , Cédrickx Godbout , Oliver Hucke , Marc-André Joly , Mélissa Leblanc , Olivier Lepage , Benoit Moreau , Julie Naud , Martin Poirier , Elisia Villemure
IPC分类号: C07D498/22 , C07D471/14 , A61K31/4375 , C07D471/22 , C07D491/147 , C07D498/14 , C07D519/00 , A61K31/496 , A61K31/506 , A61K31/5377 , A61K31/5383 , A61K45/06 , C07D491/107
CPC分类号: C07D498/22 , A61K31/4375 , A61K31/496 , A61K31/506 , A61K31/5377 , A61K31/5383 , A61K45/06 , C07D471/14 , C07D471/22 , C07D491/107 , C07D491/147 , C07D498/14 , C07D519/00
摘要: Compounds of Formula (I) wherein n, A, R1, R2, R3 and R5 are defined herein, are useful for the treatment of cytomegalovirus disease and/or infection.
摘要翻译: 其中n,A,R 1,R 2,R 3和R 5在本文中定义的式(I)化合物可用于治疗巨细胞病毒疾病和/或感染。
-
公开(公告)号:US20150080366A1
公开(公告)日:2015-03-19
申请号:US14390246
申请日:2013-04-03
申请人: Lee Fader , Pierre Louis Beaulieu , Murray Bailey , Francois Bilodeau , Rebekah J. Carson , André Giroux , Cédrickx Godbout , Oliver Hucke , Marc-André Joly , Mélissa Leblanc , Olivier Lepage , Benoit Moreau , Julie Naud , Martin Poirier , Elisia Villemure
发明人: Lee Fader , Pierre Louis Beaulieu , Murray Bailey , Francois Bilodeau , Rebekah J. Carson , André Giroux , Cédrickx Godbout , Oliver Hucke , Marc-André Joly , Mélissa Leblanc , Olivier Lepage , Benoit Moreau , Julie Naud , Martin Poirier , Elisia Villemure
IPC分类号: C07D498/22 , A61K31/5377 , A61K31/506 , A61K31/5383 , C07D491/107 , C07D471/22 , C07D471/14 , A61K45/06 , A61K31/4375 , A61K31/496
CPC分类号: C07D498/22 , A61K31/4375 , A61K31/496 , A61K31/506 , A61K31/5377 , A61K31/5383 , A61K45/06 , C07D471/14 , C07D471/22 , C07D491/107 , C07D491/147 , C07D498/14 , C07D519/00
摘要: Compounds of Formula (I) wherein n, A, R1, R2, R3 and R5 are defined herein, are useful for the treatment of cytomegalovirus disease and/or infection.
摘要翻译: 其中n,A,R 1,R 2,R 3和R 5在本文中定义的式(I)化合物可用于治疗巨细胞病毒疾病和/或感染。
-
公开(公告)号:US20120077737A1
公开(公告)日:2012-03-29
申请号:US12952777
申请日:2010-11-23
申请人: Montse Llinas-Brunet , Josée Bordeleau , Cédrickx Godbout , Mélissa Leblanc , Benoît Moreau , Jeffrey O'Meara
发明人: Montse Llinas-Brunet , Josée Bordeleau , Cédrickx Godbout , Mélissa Leblanc , Benoît Moreau , Jeffrey O'Meara
CPC分类号: C07D487/04 , A61K31/4709
摘要: Compounds of the invention, which are macrocyclic peptide analogs containing an acylsulfonamide moiety, maintain good activity against NS3 proteases containing clinically relevant resistance mutations for this class as represented by genotype 1a R155K, genotype 1b D168V and genotype 1a D168V resistance mutations. The compounds of the invention are useful as inhibitors of HCV NS3 protease for the treatment of hepatitis C viral infection.
摘要翻译: 作为含有酰基磺酰胺部分的大环肽类似物的本发明化合物对于含有基因型1a R155K,基因型1b D168V和基因型1a D168V抗性突变所表示的该类临床相关抗性突变的NS3蛋白酶保持良好的活性。 本发明的化合物可用作治疗丙型肝炎病毒感染的HCV NS3蛋白酶的抑制剂。
-
公开(公告)号:US20110294778A1
公开(公告)日:2011-12-01
申请号:US12952794
申请日:2010-11-23
申请人: Montse LLINAS-BRUNET , Josée BORDELEAU , Cédrickx GODBOUT , Mélissa LEBLANC , Benoît MOREAU , Jeffrey O'MEARA
发明人: Montse LLINAS-BRUNET , Josée BORDELEAU , Cédrickx GODBOUT , Mélissa LEBLANC , Benoît MOREAU , Jeffrey O'MEARA
IPC分类号: A61K31/4709 , A61P31/14 , C07D487/04
CPC分类号: C07D487/04 , A61K31/4709 , A61K38/00 , C07K5/0804 , C07K5/1024
摘要: Compounds of Formula (I) wherein R1, R2, R3, R4 and R5 are defined herein, maintain good activity against NS3 proteases containing clinically relevant genotype 1a R155K and genotype 1b D168V resistance mutations. The compounds are useful as inhibitors of HCV NS3 protease for the treatment of hepatitis C viral infection.
摘要翻译: 其中R1,R2,R3,R4和R5在本文中定义的式(I)化合物对含有临床相关基因型1a R155K和基因型1b D168V抗性突变的NS3蛋白酶保持良好的活性。 该化合物可用作用于治疗丙型肝炎病毒感染的HCV NS3蛋白酶的抑制剂。
-
-
-